Cortical atrophy patterns of incident MCI subtypes in the Mayo Clinic Study of Aging

Mary M Machulda1, Emily S Lundt2, Sabrina M Albertson2

  • 1Division of Neurocognitive Disorders, Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.

Abstract

Insights

Researchers found distinct patterns of brain atrophy in mild cognitive impairment (MCI) subtypes. These findings link specific cognitive deficits to brain changes, aiding early intervention strategies for cognitive decline.

Area of Science:

  • Neuroimaging
  • Neurology
  • Cognitive Science

Background:

  • Mild cognitive impairment (MCI) represents a transitional stage between normal aging and dementia.
  • Identifying distinct MCI subtypes is crucial for understanding disease heterogeneity and progression.
  • Previous research has explored structural brain changes in MCI, but subtype-specific analyses are less common.

Purpose of the Study:

  • To investigate differences in cortical thickness across empirically derived mild cognitive impairment (MCI) subtypes.
  • To correlate patterns of brain atrophy with specific cognitive impairment profiles in MCI subtypes.

Main Methods:

  • Cortical thickness was compared between four incident MCI subtypes (n=192) and cognitively unimpaired individuals (n=1257) from the Mayo Clinic Study of Aging.
  • Neuroimaging data (cortical thickness) was analyzed in relation to cognitive assessments.

Main Results:

  • The subtle cognitive impairment cluster exhibited atrophy in the entorhinal and parahippocampal cortex.
  • Amnestic, dysnomic, and dysexecutive MCI subtypes showed entorhinal cortex atrophy and thinning in temporal, parietal, and frontal isocortex, with varying patterns.
  • Distinct patterns of brain atrophy were identified for each MCI subtype, aligning with their respective cognitive deficits.

Conclusions:

  • Subtype-specific patterns of cortical atrophy correspond to distinct cognitive profiles in mild cognitive impairment.
  • Identifying MCI subtypes using cognitive and structural features can optimize clinical trial and study designs.
  • The subtle cognitive impairment cluster, with less structural change, may be a key target for early therapeutic interventions.

Related Concept Videos